221 related articles for article (PubMed ID: 8795617)
21. Structure and functional expression of the cloned rat neurotensin receptor.
Tanaka K; Masu M; Nakanishi S
Neuron; 1990 Jun; 4(6):847-54. PubMed ID: 1694443
[TBL] [Abstract][Full Text] [Related]
22. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
[TBL] [Abstract][Full Text] [Related]
23. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
[TBL] [Abstract][Full Text] [Related]
24. In vivo investigations of neurotensin receptors in adipocytes, hepatocytes and enterocytes of rat.
Piątek J; Maćkowiak P; Krauss H; Nowak D; Bogdański P
Ann Agric Environ Med; 2011; 18(2):433-6. PubMed ID: 22216825
[TBL] [Abstract][Full Text] [Related]
25. Regional characterization of brain neurotensin receptor subtypes in LS and SS mice.
Campbell AD; Jones BC; Erwin VG
Alcohol Clin Exp Res; 1991 Dec; 15(6):1011-7. PubMed ID: 1686369
[TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
[TBL] [Abstract][Full Text] [Related]
27. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.
Schotte A; Leysen JE; Laduron PM
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):400-5. PubMed ID: 3022160
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand.
Tóth F; Mallareddy JR; Tourwé D; Lipkowski AW; Bujalska-Zadrozny M; Benyhe S; Ballet S; Tóth G; Kleczkowska P
Neuropeptides; 2016 Jun; 57():15-20. PubMed ID: 26707235
[TBL] [Abstract][Full Text] [Related]
30. Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.
Betancur C; Canton M; Burgos A; Labeeuw B; Gully D; Rostène W; Pélaprat D
Eur J Pharmacol; 1998 Feb; 343(1):67-77. PubMed ID: 9551716
[TBL] [Abstract][Full Text] [Related]
31. Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor.
Botto JM; Guillemare E; Vincent JP; Mazella J
Neurosci Lett; 1997 Feb; 223(3):193-6. PubMed ID: 9080465
[TBL] [Abstract][Full Text] [Related]
32. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.
Vita N; Laurent P; Lefort S; Chalon P; Dumont X; Kaghad M; Gully D; Le Fur G; Ferrara P; Caput D
FEBS Lett; 1993 Feb; 317(1-2):139-42. PubMed ID: 8381365
[TBL] [Abstract][Full Text] [Related]
33. Species differences in brain pre-pro-neurotensin/neuromedin N mRNA distribution: the expression pattern in mice resembles more closely that of primates than rats.
Smits SM; Terwisscha van Scheltinga AF; van der Linden AJ; Burbach JP; Smidt MP
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):22-8. PubMed ID: 15193419
[TBL] [Abstract][Full Text] [Related]
34. The low affinity neurotensin receptor antagonist levocabastine impairs brain nitric oxide synthesis and mitochondrial function by independent mechanisms.
Lores-Arnaiz S; Karadayian AG; Gutnisky A; Rodríguez de Lores Arnaiz G
J Neurochem; 2017 Dec; 143(6):684-696. PubMed ID: 28975622
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological, molecular and functional characterization of glial neurotensin receptors.
Nouel D; Sarret P; Vincent JP; Mazella J; Beaudet A
Neuroscience; 1999; 94(4):1189-97. PubMed ID: 10625058
[TBL] [Abstract][Full Text] [Related]
36. Further characterization of neurotensin binding in the rat brain: levocabastine-displaceable neurotensin binding sites are not histamine-H1 receptors.
Schotte A; Leysen JE
Biochem Pharmacol; 1989 Nov; 38(21):3891-3. PubMed ID: 2597176
[No Abstract] [Full Text] [Related]
37. Radiolabeled ligands specific for the G protein-coupled state of neurotensin receptors.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1996 Dec; 67(6):2590-8. PubMed ID: 8931494
[TBL] [Abstract][Full Text] [Related]
38. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
39. Compared binding properties of 125I-labeled analogues of neurotensin and neuromedin N in rat and mouse brain.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1994 Jan; 62(1):361-8. PubMed ID: 8263537
[TBL] [Abstract][Full Text] [Related]
40. Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue.
Martin S; Vincent JP; Mazella J
J Cell Sci; 2002 Jan; 115(Pt 1):165-73. PubMed ID: 11801734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
